AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $5.358B
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| WOR | Strategic acquisition of German chemicals business | PRICE SENSITIVE | 06/04/18 | |
| WOR | Appendix 3B | 03/04/18 | ||
| WOR | PMC ADNOC Crude Flexibility Project at Ruwais Refinery | PRICE SENSITIVE | 20/03/18 | |
| WOR | PMC contract Kuwait Environmental Remediation Program | PRICE SENSITIVE | 20/03/18 | |
| WOR | Appendix 3B | 16/03/18 | ||
| WOR | Investor Day 2017 presentation | 24/05/17 | ||
| WOR Strategic acquisition of German chemicals business | |||
| 06/04/18 | PRICE SENSITIVE | ||
| WOR Appendix 3B | |||
| 03/04/18 | |||
| WOR PMC ADNOC Crude Flexibility Project at Ruwais Refinery | |||
| 20/03/18 | PRICE SENSITIVE | ||
| WOR PMC contract Kuwait Environmental Remediation Program | |||
| 20/03/18 | PRICE SENSITIVE | ||
| WOR Appendix 3B | |||
| 16/03/18 | |||
| WOR Investor Day 2017 presentation | |||
| 24/05/17 | |||
